Progress of Drug Treatment for Gastrointestinal Neuroendocrine Neoplasm
10.3969/j.issn.1008-7125.2017.09.013
- VernacularTitle:胃肠道神经内分泌肿瘤的药物治疗进展
- Author:
Yandong LI
;
Ye WANG
;
Shigang DING
- Keywords:
Neuroendocrine Tumors;
Gastrointestinal Tract;
Drug Therapy
- From:
Chinese Journal of Gastroenterology
2017;22(9):569-571
- CountryChina
- Language:Chinese
-
Abstract:
Neuroendocrine neoplasm (NEN)is a group of heterogeneous tumor originated from the neuroendocrine system,and gastrointestinal neuroendocrine neoplasm (GI-NEN)is the mostly frequently seen. The incidence of GI-NEN is increasing year by year,but the efficacy of clinical treatment is unsatisfactory. In recent years,new progress has been achieved in medical therapy of GI-NEN,including somatostatin analogues,interferon,mTOR inhibitor,vascular endothelial growth factor inhibitor and chemotherapeutic drugs. Peptide receptor radionuclide therapy also provides an additional option for treatment of metastatic GI-NEN. This article reviewed the recent progress of drug treatment for GI-NEN.
